文献速递前列腺癌男科与性医学

睾酮不驱动前列腺癌:雄激素充足与不足新框架

Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy vs Inadequacy.
PubMed 文献 · J Urol · 2026-01-13

本文综述睾酮是否驱动前列腺癌的证据,并分析该信念的来源。穿刺研究显示前列腺癌风险与内源性雄激素浓度无关,大型随机试验显示睾酮治疗组与安慰剂组前列腺癌发生率相同,已知前列腺癌患者接受睾酮治疗未增加复发或进展。作者提出雄激素充足与不足框架来解释睾酮与前列腺癌的关系。

要点

  • 睾酮不驱动前列腺癌,证据包括穿刺研究、随机试验和已知前列腺癌患者数据。
  • 雄激素是前列腺癌生长所必需,但并非唯一必需物质,且严重剥夺不致命。
  • 理解睾酮与前列腺癌关系的关键是雄激素充足与不足,而非简单驱动。

核心结论

  • 睾酮不驱动前列腺癌,雄激素充足与不足框架可科学解释睾酮与前列腺病理生理的关系。

研究设计与样本

  • MEDLINE文献综述。

主要发现

  • 穿刺研究显示前列腺癌风险与内源性雄激素浓度无关。
  • 大型随机临床试验显示接受睾酮治疗与安慰剂的男性前列腺癌发生率相同。
  • 已知前列腺癌男性接受睾酮治疗未显示复发或进展率增加。
  • 雄激素是前列腺癌生长所需,但前列腺癌生长还需其他化学物质如钙。
  • 雄激素是唯一严重剥夺不导致死亡的必需化学物质。

关键数值与推荐

  • 最佳前列腺癌生长的充足睾酮浓度发生在称为饱和点的低浓度。
  • 低于饱和点时细胞代谢受损,细胞死亡可能发生,取决于剥夺程度。

临床怎么用

  • 临床应基于雄激素充足与不足框架而非旧有信念评估睾酮治疗与前列腺癌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: (1) To review the evidence whether "testosterone drives prostate cancer," (2) to dissect the arguments supporting this belief, and (3) to present the new framework of androgen adequacy vs inadequacy to explain the relationship of testosterone and prostate cancer. MATERIALS AND METHODS: A MEDLINE review of the literature was performed. RESULTS: The belief that testosterone (T) drives prostate cancer (PCa) originated with Charles Huggins in 1941, led to a near-complete prohibition against T therapy (TTh) for 60 years, and persists today in regulatory warnings, guideline restrictions, and widespread clinical concerns. However, the evidence is now overwhelming that T does not drive PCa. Biopsy studies show that PCa risk is unrelated to endogenous androgen concentrations. Large randomized clinical trials reveal identical PCa rates in men receiving TTh vs placebo. TTh in men with known PCa has not shown increased rates of recurrence or progression. While androgens are required for PCa growth, PCa growth also requires other chemicals, for example, calcium. What is unique to androgens is it is the only required chemical that does not cause loss of life with severe deprivation. The key concept to understand the relationship of androgens and PCa is adequacy vs inadequacy. Adequate T concentrations for optimal PCa growth occur at a low concentration called the saturation point. Below this, cellular metabolism is compromised and cell death may occur depending on degree of deprivation. CONCLUSIONS: Testosterone does not drive PCa. Androgen adequacy vs inadequacy provides a scientifically sound framework to understand the relationship of testosterone and prostate pathophysiology.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Morgentaler A, Traish AM. Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy vs Inadequacy. J Urol. 2026. PMID: 41529181. doi:10.1097/JU.0000000000004936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。